Anlon Healthcare Limited

₹27.83As of Sun 8 Nov 2026, 12:00 UTC
NSE:AHCLHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 16.35%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 32.48
TSR TTM 116.39%
Mkt cap ₹14.79B
ROIC 13.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹31
11.35%
26.43%
Hold 3|0|10|3|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.34
0.35
0.36
0.36
14.52%
6.20%
1.72%
6.56%
Revenue₹B
1.804
1.846
1.833
1.858
2.87%
2.31%
0.22%
3.50%
Peers (US$152.8M)
Cap (US$)
PE
194.9M
40.75x
Capital
TTM
5Y
10Y
Leveragex
0.739
0.128
0.134
EBIT/Intx
3.875
0.455
0.457
Own earn%
(26.43)
(57.68)
(41.79)
Sh yield%
34.05
46.41
40.65
Owners
Insiders/Inst%
5.74
49.07
Short interest%
5.82
SBC / revenue%
3.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
11